If this is your company, CONTACT US to activate Packbase™ software to build your portal.

    iPSC Detection

    A key concern in iPSC-based therapeutic applications is the safety of the cell products to be transplanted into patients. Although the in vivo teratoma formation assay is an effective method to directly assess the tumorigenicity of undifferentiated cells, it is also costly and time-consuming. Now, Creative Bioarray presents a quick and cost-effective assay to detect residual undifferentiated iPSCs amongst direct differentiated cells and cells intended to be used in transplantation activities.

    • Hannah Cole
    • Web Links
    • English
    • Created 26 Mar 2024
    • Modified 26 Mar 2024
    • Hits 14